Other Species / Isoforms
  HSP20 (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S10-p
IRVPVQPsWLRRAsA
1 1
HSP20 (human) IPVPVQPSWLRRAsA S10
HSP20 (mouse) IPVPVQPsWLRRAsA S10-p
HSP20 (rat) IRVPVQPsWLRRAsA S10-p
HSP20 (pig) IPVPVQPSWLRRAsA S10
S16-p
PsWLRRAsAPLPGFS
Upstream
Downstream
22 32
HSP20 (human)
S16-p
HSP20 (mouse)
S16-p
HSP20 (rat)
S16-p
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • apoptosis, inhibited
  • cytoskeletal reorganization
Putative in vivo kinases:
  • PKACA (rat)
Treatment
  • cAMP_analog
  • cGMP_analog
  • CGRP
  • colforsin
  • exercise
  • H-89
  • insulin
  • isoproterenol
  • KT5720
  • PDGF
  • racepinefrine
  • rolipram
  • SNP
HSP20 (human) PSWLRRAsAPLPGLS S16-p
HSP20 (mouse) PsWLRRAsAPLPGFS S16-p
HSP20 (rat) PsWLRRAsAPLPGFS S16-p
HSP20 (pig) PSWLRRAsAPLPGLS S16-p
S59
PYYLRAPSVALPTAQ
0 4
HSP20 (human) PYYLRAPsVALPVAQ S59-p
HSP20 (mouse) PYYLRAPSVALPTAQ S59
HSP20 (rat) PYYLRAPSVALPTAQ S59
HSP20 (pig) PYYLRAPSVALPTAQ S59
S84
LLDVKHFSPEEISVK
0 3
HSP20 (human) LLDVKHFsPEEIAVK S84-p
HSP20 (mouse) LLDVKHFLPEEISVK L84
HSP20 (rat) LLDVKHFSPEEISVK S84
HSP20 (pig) LLDVKHFSPEEIAVK S84
S157-p
SAQASLPsPPAAK__
Upstream
2 3
Treatment
  • CGRP
  • insulin
  • racepinefrine
  • rapamycin
  • wortmannin
HSP20 (human) PASAQAPPPAAAK__ P155
HSP20 (mouse) SAQAQLPsPPAAK__ S157-p
HSP20 (rat) SAQASLPsPPAAK__ S157-p
HSP20 (pig) PAQGPLPSPPAAAK_ S157